BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase

  T2 Biosystems, Inc. announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

  September 7, 2023

   · 

  1 min read
• Pharm Country

  Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase

  Hyperfine, Inc. today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually.

  September 7, 2023

   · 

  5 min read
• Biotech Bay

  Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference

  Pasithea Therapeutics Corp. announced today that Pasithea’s management team will participate in the H.C. Wainwright 25th Annual Global Conference.

  September 7, 2023

   · 

  1 min read
• Pharm Country

  IMUNON to Host Virtual R&D Day on September 14th Beginning at 4:00 p.m. ET

  IMUNON, Inc. announces that it will hold a virtual R&D Day event on September 14th beginning at 4:00 p.m. Eastern time.

  September 7, 2023

   · 

  4 min read
• Lone Star Bio

  Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference

  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the H.C. Wainwright & Co. 25th Annual Global Investment Conference, taking place September 11-13, 2023.

  September 7, 2023

   · 

  2 min read
• Deals

  Theralase(R) Closes Private Placement Equity Financing

  Theralase Technologies Inc. is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”).

  September 7, 2023

   · 

  6 min read
• Business

  CENTOGENE Reports First Half 2023 Financial Results

  Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced its unaudited financial results for the six months ended June 30, 2023.

  September 7, 2023

   · 

  21 min read
• Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer

  Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment today announces the appointment of Dr Henno Welgemoed

  September 7, 2023

   · 

  3 min read
• Genetown

  Mustang Bio to Participate in Upcoming September 2023 Investor Conferences

  Mustang Bio, Inc. announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two upcoming investor conferences in New York City.

  September 7, 2023

   · 

  1 min read
• Nanostics Receives Provisional CPSA Accreditation for its Clinical Laboratory

  Nanostics Inc. announced that the College of Physicians and Surgeons of Alberta granted provisional accreditation to Nanostics Clinical Laboratory in Edmonton, Alberta, Canada.

  September 7, 2023

   · 

  2 min read